The Book Washington Does Not Want You To Read. An indictment of Big Medicine and Their Suppression of the Cesium Cancer Therapy.

Cancer Stories

Success Stories

Helene Hendrixson: Cancer Survivor

Like all material provided on the Cancer Cover-Up Web site the “Success Story” below is provided for informational or educational purposes only. Each Success Story represents the personal experience of the individual discussed. It is not intended for the diagnosis, treatment or evaluation of any specific disease or condition. The symptoms, appropriate treatment and prognosis for specific diseases often vary among individuals. You should always consult a physician regarding the applicability of any opinions or recommendations with respect to your symptoms or medical condition.

The news Helene Hendrixson got on January 14, 1997 couldn’t have been worse. Helene’s doctor told her that she had Stage IV non-Hodgkins Lymphoma, or NHL. NHL has become the fastest growing type of cancer, with an estimated 50,000 new cases each year. When caught early non-Hodgkins Lymphoma will often respond to conventional techniques such as chemotherapy and radiation. The prognosis for more advanced cases such as Helene’s, however, was far less hopeful, with at best 30% to 40% of patients responding to traditional methods. For those who do not respond, the diagnosis is a death sentence.

In other words, even with conventional treatment, the outlook for Helene was not encouraging.

To make matters worse, her doctor held out little hope that these conventional means would help. Her cancer was too advanced. He suggested she enter a clinical trial at the National Cancer Institute – what he didn’t tell her, however, was that only 5% of the patients in Phase I clinical trials ever derive any benefit from the experiment.

But Helene was not the type of person to throw in the towel without a fight. She was determined to find a way to beat the odds. Then in February, her aunt called with an option that seemed to offer a ray of hope. She had heard of an alternative treatment using the mineral cesium and a highly concentrated form of the whole leaf of the aloe vera plant that was having considerable success.

She decided to take a chance.

In April, she began taking the cesium according to the High pH protocol.

The following month she began taking the aloe vera concentrate.

Meanwhile, Helen’s doctor had arranged for her to enter a clinical trial sponsored by the National Cancer Institute.

The trial was named “Phase I Adjuvant Study of Tumor-Derived Immunoglobulin Ideotype Combined with QS-21 for Follicular Lymphomas.”

Its purpose was to determine if it were possible to combine chemotherapy with a vaccine to treat the type of non-Hodgkins Lymphoma that Helene had developed.

Under the trial’s protocol, Helene would first have a small, cancerous lymph node removed from which the doctors hoped to grow a vaccine. She would then be subjected to an initial course of chemotherapy. A second course of chemotherapy would also be administered. Those patients who had responded to the drug and achieved “complete clinical remission” would then be given the vaccine derived from their tumors along with another drug, QS-21 (a plant extract) that was intended to boost their immune system.

A key point, however, was never fully explained to Helene. The implications of it being a Phase I trial.

Phase I trials are described by the National Cancer Institute as follows:
“The first step in testing a new treatment in humans. These studies test the best way to give a new treatment (for example, by mouth, intravenous infusion, or injection) and the best dose. The dose is usually increased a little at a time in order to find the highest dose that does not cause harmful side effects. Because little is known about the possible risks and benefits of the treatments being tested, phase I trials usually include only a small number of patients who have not been helped by other treatments.”

Still, Helene initially went along with her doctor’s recommendation and on April 10th had a lymph node removed so that the vaccine could be grown. The only trouble is, they put the biopsy sample in the wrong type of solution and destroyed it. This was hardly a way to build confidence. Unfortunately, she would eventually discover that this sort of incompetence was typical of the medical personnel working on the study.

They also let her know about the two courses of chemotherapy she would have to submit to.

Helene grew increasingly disturbed by what she viewed as ineptness and insensitivity on the part of the NCI researchers. It seemed as though they felt that the patient was only there as a convenience to their research. How could they destroy a biopsy sample? Didn’t they realize a patient had to undergo surgery to harvest the tissue and that a second surgery would be required to replace the damaged sample? Why did it seem that they were not being candid? Why did they seem so intent on treating her like a lab rat rather than a human being?

Cancer Cover-Up:

An indictment of Big Medicine and Their Suppression of the Cesium Cancer Therapy.

Cancer Cover Up

Soft or Hard Cover

All these factors contributed to her growing unease. So, too, did their insistence that she receive chemotherapy.

Her concern over the prospect of chemotherapy was heightened by what her doctor told her about the treatment. “Once you begin chemotherapy, your ‘death clock’ starts running.” Without chemotherapy, he said, she might actually survive longer. If this were true, why were they so insistent that she undergo a treatment that might actually reduce her chances for survival?

More important, it seemed as though the combination of cesium and concentrated aloe vera were doing the job. As a result, the NIH experiment was looking less attractive every day.

By May, just one month after beginning the High pH Therapy, she noticed that the lumps in her lymph nodes were going down. As this process continued over the following year, Helene became hopeful. In fact, by April of 1998 – twelve months after initiating the High pH Therapy – the swollen lymph nodes had completely disappeared. But still, she had to be sure it was the cesium and aloe vera, so she decided to take a risk. Helene stopped taking the supplements, and within a few days, her tumors began to reappear.

She began taking the cesium and aloe vera concentrate again. Within two days, the tumors were gone.

Helene would try this risky procedure a second time, with similar results.

Then, in August of 1998, when her tumors had been gone for several months, Helene decided to discontinue taking the cesium, but continued taking the aloe vera concentrate. This time, the tumors did not return.

Today, five and a half years after she was first diagnosed with non-Hodgkins Lymphoma and roughly four and a half years after completing the cesium protocol, Helene Hendrixson is still cancer free.

What is more remarkable, however, is the continuing resistance of her doctors to even consider the possibility that her complete remission could have been achieved through the use of cesium and aloe vera. Whenever she attempts to bring the subject up with them, their only response is derisive laughter – this despite the tangible evidence from Helene’s astounding recovery that the treatment worked! They know that Helene took no other treatment, and yet they refuse to even consider the possibility that a non-traditional, natural therapy might have helped!

What is perhaps the most disturbing about their refusal to recognize the truth, however, are the consequences of such a close-minded attitude for the doctors’ other patients – especially those who had exhausted all conventional approaches. Wouldn’t such patients at least want to know that they had one last chance for survival? Wouldn’t they want the opportunity to decide for themselves whether or not to try cesium and aloe? Even if the doctors had doubts about the effectiveness of the High pH Therapy, the chance for realizing some benefit could hardly be worse than the 5% (at best) offered by a Phase I trial. How many patients may have died because their physicians withheld this potentially life-saving information?

And, for that matter, what of the phase I clinical trial Helene’s doctor was so insistent she participate in? Although the results have not been published, it does not appear that the trial was successful. Indeed, the doctors running the trial initiated a new one, using Interleuken-2 as an immune system booster, abandoning the plant extract they were using in the trial Helene was supposed to join. So, in the end, Helene’s refusal to allow herself to become a human guinea pig probably saved her life.

To Helene, however, what is most important is that she is cancer-free five and one half years after her initial diagnosis – an achievement the cancer establishment uses to define a “cure.” Her doctors may not want to recognize the truth, but for Helene, her continued survival is evidence enough.

portrait-Kathleen-Deoul-150x150About Kathleen Deoul

Internationally acclaimed wellness advocate Kathleen B. Deoul founded Cassandra Books. In taking this step, Kathleen hopes to bring her message of health and hope to people all over the world. Full profile

Take Action!

You can help in the fight for your life!

Legislators need to hear from their constituents. View our resources to help you get in contact with your legislators.